<DOC>
	<DOCNO>NCT00549783</DOCNO>
	<brief_summary>This study investigate patient stroke suffer spasticity might benefit give BOTOX® addition normal Standard Care . Spasticity characterize stiffness frequent cramp accompany pain abnormal movement prevent carry everyday task walk get dress . BOTOX® neurotoxin , use prevent contraction muscle fibre show reduce spasticity significantly . Patients enrol study 33 location Europe Canada . Study participation last 1 year .</brief_summary>
	<brief_title>BOTOX® Economic Spasticity Trial ( BEST )</brief_title>
	<detailed_description />
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Patients stroke due primary cerebral hemorrhage/infarction Subarachnoid hemorrhage produce upper motor syndrome affect one body side result hemiparalysis/plegia Patients fixed contracture result spasticity upper low limb plan treat and/or patient cause spasticity ( e.g . multiple sclerosis , spinal cord injury , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2012</verification_date>
</DOC>